These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37213535)

  • 1. Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease.
    Delgado-Álvarez A; Nielsen TR; Delgado-Alonso C; Valles-Salgado M; López-Carbonero JI; García-Ramos R; Gil-Moreno MJ; Díez-Cirarda M; Matías-Guiu J; Matias-Guiu JA
    Front Aging Neurosci; 2023; 15():1134111. PubMed ID: 37213535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments.
    Ophey A; Wolfsgruber S; Roeske S; Polcher A; Spottke A; Frölich L; Hüll M; Jessen F; Kornhuber J; Maier W; Peters O; Ramirez A; Wiltfang J; Liepelt-Scarfone I; Becker S; Berg D; Schulz JB; Reetz K; Wojtala J; Kassubek J; Storch A; Balzer-Geldsetzer M; Hilker-Roggendorf R; Witt K; Mollenhauer B; Trenkwalder C; Wittchen HU; Riedel O; Dodel R; Wagner M; Kalbe E
    Alzheimers Dement (Amst); 2021; 13(1):e12223. PubMed ID: 34541284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease.
    Conca F; Esposito V; Catricalà E; Manenti R; L'Abbate F; Quaranta D; Giuffrè GM; Rossetto F; Solca F; Orso B; Inguscio E; Crepaldi V; De Matteis M; Rotondo E; Manera M; Caruso G; Catania V; Canu E; Rundo F; Cotta Ramusino M; Filippi M; Fundarò C; Piras F; Arighi A; Tiraboschi P; Stanzani Maserati M; Pardini M; Poletti B; Silani V; Marra C; Di Tella S; Cotelli M; Lodi R; Tagliavini F; Cappa SF
    Alzheimers Res Ther; 2024 May; 16(1):98. PubMed ID: 38704608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normative Data in Cross-Cultural Neuropsychological Instruments in Spaniards and Colombians Living in Spain.
    Delgado-Álvarez A; Delgado-Alonso C; Valles-Salgado M; Gil-Moreno MJ; Fernández-Romero L; Matías-Guiu J; Matias-Guiu JA
    J Alzheimers Dis; 2023; 96(3):1231-1241. PubMed ID: 37927267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil.
    Brandão PRP; Pereira DA; Grippe TC; Bispo DDC; Maluf FB; Yunes MP; Nunes Filho G; Alves CHL; Pagonabarraga J; Kulisevsky J; da Costa AML; Serafim CFDV; Ferreira ACDB; Bastos AMM; Belchior ACF; de Almeida BLC; de Almeida E Castro BM; Matos MS; de Matos RC; Rios GA; Carneiro LO; da Mota BCC; Castro LEDR; Rocha VLS; Tavares MCH; Cardoso F
    Mov Disord Clin Pract; 2023 Mar; 10(3):452-465. PubMed ID: 36949793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIMHANS Neuropsychological Battery for Elderly in Parkinson's Disease Patients: Validation and Diagnosis using MDS PD-MCI Task Force Criteria in Indian Population.
    Botta R; Keshav KJ; Kutty B; Mahadevan A; Pal PK; Yadav R
    Ann Indian Acad Neurol; 2023; 26(3):247-255. PubMed ID: 37538425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mattis Dementia Rating Scale 2: screening for MCI and dementia.
    Matteau E; Dupré N; Langlois M; Jean L; Thivierge S; Provencher P; Simard M
    Am J Alzheimers Dis Other Demen; 2011 Aug; 26(5):389-98. PubMed ID: 21697143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short Digital Spatial Memory Test Detects Impairment in Alzheimer's Disease and Mild Cognitive Impairment.
    Poos JM; van der Ham IJM; Leeuwis AE; Pijnenburg YAL; van der Flier WM; Postma A
    Brain Sci; 2021 Oct; 11(10):. PubMed ID: 34679414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Accurate Self-appraisal is Equally Likely in MCI from Parkinson's Disease and Alzheimer's Disease.
    Pillai JA; Bonner-Jackson A; Floden D; Fernandez H; Leverenz JB
    Mov Disord Clin Pract; 2018; 5(3):283-289. PubMed ID: 30363404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?
    Wen MC; Chan LL; Tan LCS; Tan EK
    Transl Neurodegener; 2017; 6():24. PubMed ID: 28919975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study.
    Caballero HS; McFall GP; Gee M; MacDonald S; Phillips NA; Fogarty J; Montero-Odasso M; Camicioli R; Dixon RA
    J Alzheimers Dis; 2024 Jun; ():. PubMed ID: 38875040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social Cognition and Mild Cognitive Impairment in Mid-Stage Parkinson's Disease.
    Fernández-Fernández R; Lahera G; Fernández-Rodríguez B; Guida P; Trompeta C; Mata-Marín D; Gasca-Salas C
    Behav Sci (Basel); 2024 Jan; 14(2):. PubMed ID: 38392454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of HVLT-R, BVMT-R, and RBANS Learning Slope Scores along the Alzheimer's Continuum.
    Hammers DB; Suhrie K; Dixon A; Gradwohl BD; Duff K; Spencer RJ
    Arch Clin Neuropsychol; 2022 Jan; 37(1):78-90. PubMed ID: 33899087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Differential Diagnostics Potential of Uniform Data Set 2 Neuropsychology Battery Using Alzheimer's Disease Biomarkers.
    Čihák M; Horáková H; Vyhnálek M; Veverová K; Matušková V; Laczó J; Hort J; Nikolai T
    Arch Clin Neuropsychol; 2024 Apr; ():. PubMed ID: 38582748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal.
    Bohnen JLB; Albin RL; Bohnen NI
    Front Neurol; 2023; 14():1123290. PubMed ID: 36846143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial Emotion Recognition in Older Adults With Cognitive Complaints.
    Shim Y
    Dement Neurocogn Disord; 2023 Oct; 22(4):158-168. PubMed ID: 38025409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum.
    Soch J; Richter A; Kizilirmak JM; Schütze H; Ziegler G; Altenstein S; Brosseron F; Dechent P; Fliessbach K; Freiesleben SD; Glanz W; Gref D; Heneka MT; Hetzer S; Incesoy EI; Kilimann I; Kimmich O; Kleineidam L; Kuhn E; Laske C; Lohse A; Lüsebrink F; Munk MH; Peters O; Preis L; Priller J; Ramirez A; Roeske S; Rostamzadeh A; Roy-Kluth N; Scheffler K; Schmid M; Schneider A; Spottke A; Spruth EJ; Teipel S; Wiltfang J; Jessen F; Wagner M; Düzel E; Schott BH
    Brain; 2024 May; ():. PubMed ID: 38743817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and Cultural Generalisability of a 5-Minute AI-Based, Computerised Cognitive Assessment in Mild Cognitive Impairment and Alzheimer's Dementia.
    Kalafatis C; Modarres MH; Apostolou P; Marefat H; Khanbagi M; Karimi H; Vahabi Z; Aarsland D; Khaligh-Razavi SM
    Front Psychiatry; 2021; 12():706695. PubMed ID: 34366938
    [No Abstract]   [Full Text] [Related]  

  • 19. The Montreal Cognitive Assessment: Is It Suitable for Identifying Mild Cognitive Impairment in Parkinson's Disease?
    Rosenblum S; Meyer S; Gemerman N; Mentzer L; Richardson A; Israeli-Korn S; Livneh V; Karmon TF; Nevo T; Yahalom G; Hassin-Baer S
    Mov Disord Clin Pract; 2020 Aug; 7(6):648-655. PubMed ID: 32775510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia.
    Parra MA; Ascencio LL; Urquina HF; Manes F; Ibáñez AM
    Front Neurol; 2012; 3():172. PubMed ID: 23227021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.